SUMMARY Different methods of performing the (14C) aminopyrine breath test have been assessed.
the method selected, since it gave the best discrimination between patients with hepatocellular diseases and normal subjects (5-2 + 0-2%, mean + SEM). Reduced values occurred in patients with chronic active hepatitis (with and without cirrhosis) (1-5 + 0 2%), alcoholic cirrhosis (1'7 + 0 4 %) and hepatitis (2-5 ± 0 3 %), and late primary biliary cirrhosis suggesting defective microsomal function with respect to demethylation. Normal results were common in early primary biliary cirrhosis. Two weeks of prednisolone therapy caused some improvement in the breath test in nine of 10 patients with chronic active hepatitis. It is concluded that the (14C) aminopyrine breath test is a simple test for detecting hepatocellular dysfunction, but has no obvious diagnostic advantage over the determination of serum aspartate transaminase and two hour post-prandial bile-acids.
Microsomal enzymes play an important role in drug metabolism. Evidence that their activity may be reduced in liver disease (Schoene et al., 1972 ) is indirect and is limited to studies with selected drugs or chemicals, involving different enzymes for their metabolism. Lauterburg and Bircher (1976) showed in animal studies that the 14CO2 exhaled after intravenous administration of aminopyrine specifically labelled at the two 4-N-methyl groups ( Fig. 1) gives quantitative information on the hepatic demethylation of the drug. Subsequently a breath test, after oral administration of (14C) aminopyrine, has been developed which provides a simple procedure for the quantitative assessment of microsomal function in man (Hepner and Vesell, 1974; Bircher et al., 1976a) .
Several different procedures for the test have been proposed (Hepner and Vesell, 1975; Bircher et al., 1976a, b) and these have been evaluated in this study. The value of the test in patients with primary biliary cirrhosis (PBC) (Levi et al., 1968 ). An accurate assessment of the dose administered was obtained by diluting an aliquot of the stock 14C aminopyrine with 10% (v/v) aqueous ethanol to give a solution with a concentration of 1 ,uCi per litre and then adding 1 ml to 10 ml scintillant. All estimations were made in duplicate.
Determination ofdecay constant ofspecific activity of 14CO2 in breath (KB) Samples of 14CO2 were collected before the test and then half, one, two, three, five, and eight hours after the administration of the aminopyrine. The specific activities were plotted on semi-logarithmic paper and the value for the half life in hours (T*) calculated by least square analysis of the results obtained after two hours, when the specific activities declined exponentially. The decay constant KB was calculated 0-693 from the formula KB = x 100 and the results expressed as percentage per hour.
Fractional disappearance ofaminopyrine from plasma (Kp) Twenty subjects received a dose of non-labelled aminopyrine (9 mg/kg) simultaneously with the isotope. Plasma samples were obtained at zero time and two, four, six, and eight hours later. The aminopyrine content was assayed spectrophotometrically at 260 m,u in acid after extraction into ethylene dichloride; allowance was made for the formation of the metabolites, N-acetyl 4-aminoantipyrine and 4-amino-antipyrine by the method of Brodie and Axelrod (1950) .
Two hour breath test (SA2h) Expired 14CO2 was estimated two hours after the administration of the 14C aminopyrine. It was assumed that the C02 production rate did not change between 1 i and 2i hours. Results were expressed as a percentage of the dose administered as previously indicated. The values obtained were less than those of Hepner and Vesell (1975) , who determined the cumulative excretion over two hours. They also differ from the two hour values of Bircher et al. (1976a b,) , who did not allow for endogenous C02 in their calculations. Results for the groups were compared using Student's t test with a confidence limit of 95%.
Results

COMPARISON OF METHODS
Examples of the specific activity curves for C02 following the administration of (14C) aminopyrine are given in Fig. 2 . The peak of radioactivity excretion was reached within two hours after the drug administration in 45 (r = 0-88, n = 20, p < 0 001).
When the results for SA2h were compared with those for KB in 47 patients a good correlation was also obtained (r = 0-72, p < 0-001). In a comparison between six controls and nine cirrhotic patients, using the results for SA2h, only one of the cirrhotic patients had a value within the range of 95 % of the controls, whereas with the results for KB four patients had normal results. This suggested that the determination of SA2h provided the best test of discrimination between cirrhotics and normal subjects. No improvement in discrimination was obtained using values for peak 14CO2 specific activity, or cumulative radioactivity in breath for the first two hours of the test. All subsequent studies were therefore performed using a single determination of 14CO2 specific activity at two hours. Studies in four controls and seven patients with liver disease showed that the values for SA2h tended to be slightly lower when a loading dose was given, but the difference between the mean values was not statistically significant.
REPRODUCIBILITY OF TWO HOUR BREATH TEST
Six patients with liver disease and two normal subjects had the two hour breath test repeated after five days. The coefficient of variation for the two sets of results, which had mean values of 3-48 % and 3-53 % respectively, was 6-1 %.
PATIENT STUDIES WITH TWO HOUR BREATH TEST (Figs. 3 and 4) The results for the 15 control subjects ranged fromr 4-1 to 6-5% (5-2 ± 0-2%, mean ± SEM). In contrast, the values for the 27 patients with CAH, with and without cirrhosis, ranged from 0-2 and 3-8%; the mean value of 1-5 ± 0-2% was significantly different from that for the controls (p < 0 001).
The mean value for 21 patients with symptomatic primary biliary cirrhosis was 4-1 ± 0-3 %. This was significantly lower than that for the controls (i? < 0-001) and higher than that for the CAH patients (p < 0-001). Fifteen of the 21 PBC patients, however, had values within the normal range; all those whco had subnormal results had histological and biochemical evidence of late PBC.
The 27 patients with alcoholic liver disease were grouped according to histological diagnosis (Fig. 4) . Eleven had alcoholic cirrhosis with a mean value of 1-7 + 0-4 %; this was significantly different from that of the controls (p < 0-001) but not from the CAH group. Two of the alcoholic cirrhotics had values within the normal range (3-6 and 4-0%). The seven patients with alcoholic hepatitis without cirrhosis had a mean value of 2-5 ± 0-3 %; this differed signi-
EFFECT OF PREDNISOLONE AND AZATHIOPRINE IN CAH
Eight patients with histologically confirmed HB8Ag negative CAH and five patients with HB,Ag positive CAH were studied using the two hour test before starting prednisolone (20-30 mg daily); the test was repeated after one week in 12 patients and after two weeks in 10 patients. After one week the two hour breath test had improved in 10 of the 12 patients (mean improvement 0-73 ± 0-87%) and after two weeks had improved in nine of 10 patients (mean improvement 0-81 ± 0-94 %). Six of these increased values shown in Fig. 5 were higher than could be expected from day to day variation. The overall improvement in the results for the 13 patients, however, just failed to reach conventional significance (p < 0-10).
Other tests of liver function were performed at the same time as the breath test. In the 10 patients who had two weeks treatment serum aspartate transaminase values fell significantly (p < 0-01) after steroid therapy but there was no significant improvement in the breath test (p < 0-15), serum total bilirubin (p < 0-30), or serum albumin (p < 0-45). The two hour post-prandial bile acid determinations made at the time of the breath test in six patients were not significantly altered by the prednisolone therapy.
Two patients, one with HBsAg positive CAH and one with HBsAg negative CAH, were studied before and after azathioprine (100 mg daily). The condition of the HBsAg positive patient deteriorated and the results for the breath test decreased (1.9% before treatment; 1-4% after one week; 088% after two weeks), whereas the results for the HBrAg negative patient did not change (1-6% before treatment; 1-5% after one week; 1-7% after two weeks). (Brodie and Axelrod, 1950) , so that an estimate of the capacity of the liver for demethylation can be obtained by measuring the expired 14CO2 after an oral dose of (14C) aminopyrine. Determination of the decay constant KB (Bircher et al., 1976a) is certainly a more acceptable test for the patient than an enzyme assay on a liver biopsy specimen (Schoene et al., 1972) , but for outpatients it has the disadvantage of taking eight hours. The value of an empirical test, in which only a two hour measurement was made (Hepner and Vesell, 1975) , was therefore investigated. A constant of 9 mmol/kg/h for endogenous CO2 production was included in the calculation so that the results could be expressed in terms of percentage of dose administered per hour at two hours; this constant is, however, influenced by such factors as physical exercise, which might be important when outpatients are studied. Physical activity was therefore restricted as far as possible in these patients and a second breath test was always performed under the same conditions as the first.
The results of the two hour breath test using a tracer dose were compared with those obtained after a loading dose of 9 mg/kg in 11 patients, since this dose had been used when the breath and plasma tests were performed simultaneously. The administration of a large dose of aminopyrine did not improve the discrimination capacity of the breath test, so a tracer dose only was given in subsequent studies.
In contrast to the breath test the rate of aminopyrine plasma disappearance rate reflects both demethylation and the different catabolic processes which the compound undergoes (Brodie and Axelrod, 1950) . This could explain the small difference observed for the values of Kp and KB. In our studies SA2h correlated better with Kp than KB, specially in normal subjects.
Our results are essentially similar to those of Bircher and coworkers (1976) and Hepner and Vesell (1975) . Low values for the breath test at two hours are characteristic of hepatocellular disease. In contrast, normal values are common in PBC where hepatocellular failure is a late feature. Although more studies in those with more marked cholestatic jaundice are necessary, our data suggest that cholestasis per se is not as important as hepatocellular dysfunction in affecting demethylation activity. All the alcoholic patients studied had some degree of liver disease; reduced values were seen in the cirrhotic and hepatitic subgroups and, as would be expected, were related to the degree of hepatocellular failure. In the miscellaneous group low results were observed in patients with hepatocellular damage and metastatic liver disease. (Schalm et al., 1976) . This observation supports the hypothesis that corticosteroids may induce microsomal enzymes, possibly by antagonising the action of a post-transcriptional repressor (Gelehrter, 1973) . It might, however, also reflect an improvement in the overall degree of hepatocellular function, rather than a specific inducing effect. In contrast, no effect was seen in two patients treated with azathioprine, which acts predominantly as an immunosuppressant. This is in agreement with previous studies with indocyanine green which showed no improvement in hepatic reserve (Rikkers and Sherlock, 1975) .
The breath test appears to be more sensitive in detecting hepatocellular disease than liver function tests such as serum albumin, serum total bilirubin, and prothrombin time. Its efficiency as a screening test for hepatocellular dysfunction was, however, similar to that of serum aspartate transaminase and serum two hour post-prandial bile acids determinations. Others have shown that the results of the breath test compare well with such quantitative tests of hepatic function as bromosulphthalein excretion and galactose elimination capacity (Bircher et al., 1976a, b) . One limitation of the test is that it requires the administration of a small dose of radioactivity (2 uCi) but most of it is quickly eliminated in the breath. In centres where mass spectrometry is available (13C) aminopyrine could be used as an alternative (Schneider et al., 1975) . Although a hypersensitivity reaction to aminopyrine has been described, this is rare Mustala, 1970, 1972) and it has not been reported after a single dose; moreover, only a tracer dose (164 nmol) is given for this test.
The (14C) aminopyrine breath test is easy to perform and involves a relatively non-invasive technique. It appears to be a useful screening test for hepatocellular disease, and complements other tests which measure different activities of the liver. Any real advantage over other standard laboratory investigations has, however, to be established.
